Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$0.74 - $1.83 $37 - $91
-50 Reduced 59.52%
34 $1,000
Q3 2022

Nov 08, 2022

BUY
$1.51 - $2.88 $51 - $97
34 Added 68.0%
84 $2,000
Q2 2022

Sep 06, 2022

BUY
$1.24 - $2.33 $62 - $116
50 New
50 $1,000
Q2 2022

Aug 12, 2022

SELL
$1.24 - $2.33 $62 - $116
-50 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$2.0 - $4.9 $100 - $245
50 New
50 $0
Q3 2021

Oct 06, 2021

SELL
$7.41 - $10.99 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$6.35 - $10.0 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

SELL
$7.03 - $16.51 $7,030 - $16,510
-1,000 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$5.76 - $11.95 $6,347 - $13,168
-1,102 Reduced 52.43%
1,000 $7,000
Q3 2020

Oct 29, 2020

BUY
$6.17 - $18.82 $6,799 - $20,739
1,102 Added 110.2%
2,102 $23,000
Q2 2020

Aug 05, 2020

BUY
$1.73 - $6.76 $1,730 - $6,760
1,000 New
1,000 $6,000
Q1 2020

May 12, 2020

BUY
$1.57 - $4.76 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$1.45 - $4.17 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$2.05 - $2.69 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

SELL
$1.86 - $5.94 $6,928 - $22,126
-3,725 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$2.01 - $4.24 $1,205 - $2,544
600 Added 19.2%
3,725 $8,000
Q3 2018

Oct 25, 2018

SELL
$4.22 - $7.5 $3,903 - $6,937
-925 Reduced 22.84%
3,125 $0
Q2 2018

Aug 07, 2018

SELL
$4.75 - $8.0 $13,775 - $23,200
-2,900 Reduced 41.73%
4,050 $0
Q1 2018

Jun 03, 2019

BUY
$4.5 - $9.95 $13,050 - $28,854
2,900 Added 71.6%
6,950 $27,000
Q1 2018

May 09, 2018

SELL
$4.5 - $9.95 $8,550 - $18,905
-1,900 Reduced 31.93%
4,050 $0
Q4 2017

Jan 24, 2018

BUY
$1.75 - $3.8 $3,500 - $7,600
2,000 Added 50.63%
5,950 $0
Q3 2017

Oct 30, 2017

SELL
$1.63 - $2.0 $652 - $800
-400 Reduced 9.2%
3,950 $7,000
Q2 2017

Jun 03, 2019

BUY
N/A
1,500 Added 52.63%
4,350 $9,000
Q1 2017

Jun 03, 2019

SELL
N/A
-4,700 Reduced 62.25%
2,850 $11,000
Q4 2016

Jun 03, 2019

BUY
N/A
3,800 Added 101.33%
7,550 $37,000
Q2 2016

Jun 03, 2019

BUY
N/A
3,750
3,750 $21,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.